Global SNRIs Antidepressants Market Growth 2024-2030

Global SNRIs Antidepressants Market Growth 2024-2030

One of the most commonly used classes of drugs to treat depression is selective serotonin reuptake inhibitors (SSRIs), and another class of antidepressants is serotonin and norepinephrine reuptake inhibitors (SNRIs). SNRIs play an important role in regulating emotion and sensitivity to pain. The biggest feature is that it can improve the physical pain symptoms associated with depression, and its side effects on sexual function are far less than other first-line drugs. They mainly include Venlafaxine and Duloxetine.

The global SNRIs Antidepressants market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.

LP Information, Inc. (LPI) ' newest research report, the “SNRIs Antidepressants Industry Forecast” looks at past sales and reviews total world SNRIs Antidepressants sales in 2023, providing a comprehensive analysis by region and market sector of projected SNRIs Antidepressants sales for 2024 through 2030. With SNRIs Antidepressants sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world SNRIs Antidepressants industry.

This Insight Report provides a comprehensive analysis of the global SNRIs Antidepressants landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on SNRIs Antidepressants portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global SNRIs Antidepressants market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for SNRIs Antidepressants and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global SNRIs Antidepressants.

United States market for SNRIs Antidepressants is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for SNRIs Antidepressants is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for SNRIs Antidepressants is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key SNRIs Antidepressants players cover Eli Lilly, Shanghai Zhongxi, Jiangsu Enhua Pharmaceutical, Pfizer and Kanghong Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of SNRIs Antidepressants market by product type, application, key manufacturers and key regions and countries.

Segmentation by type
Venlafaxine
Duloxetine

Segmentation by application
Hospital
Clinic

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Eli Lilly
Shanghai Zhongxi
Jiangsu Enhua Pharmaceutical
Pfizer
Kanghong Pharmaceutical
Aurobindo
Zydus
Teva
Renfu Pharmaceutical
Suzhou Fourth Pharmaceutical Factory
Sandoz
Shandong Xinqi Pharmaceutical
Chongqing Yaoyou Pharmaceutical
Lupin
Sun Pharma

Key Questions Addressed in this Report

What is the 10-year outlook for the global SNRIs Antidepressants market?

What factors are driving SNRIs Antidepressants market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do SNRIs Antidepressants market opportunities vary by end market size?

How does SNRIs Antidepressants break out type, application?

Please note: The report will take approximately 2 business days to prepare and deliver.